Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Breast Cancer

The Detection Value of 18F-FDG PET/MR for Breast Cancer Liver Metastasis

Yuanfan Xu and Chenjie Xu
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1494;
Yuanfan Xu
1HangZhou Universal Medical Imaging Diagnostic Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chenjie Xu
1HangZhou Universal Medical Imaging Diagnostic Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P1494

Introduction: To explore the value of 18F-FDG PET/MR systemic imaging in detecting liver metastasis of breast cancer.

Methods: The PET/MR and PET/CT imaging of 78 cases of liver metastasis were analyzed retrospectively. On the same day, whole body 18F-FDG PET/CT imaging and PET/MR imaging were performed, taking pathological and clinical diagnosis as the gold standard to compare the differences in the lesions.

Results: 78 patients with liver cancer, a total of 106 intrahepatic metastasis lesions, PET/MR detected all lesions, and PET/CT detected 69 lesions, with significant statistical differences (P<0.01). Among them, 25 lesions were PET-MR positive, while PET-CT was negative; and 19 other lesions were negative for both equipment PET intake. Compared with PET/CT, PET/MR changed the diagnostic results of 28 (35.9%) patients.

Conclusions: The detection rate of PET/MR for breast cancer liver metastasis is significantly better than that of PET/CT.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Detection Value of 18F-FDG PET/MR for Breast Cancer Liver Metastasis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Detection Value of 18F-FDG PET/MR for Breast Cancer Liver Metastasis
Yuanfan Xu, Chenjie Xu
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1494;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Detection Value of 18F-FDG PET/MR for Breast Cancer Liver Metastasis
Yuanfan Xu, Chenjie Xu
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1494;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • FAPI Versus 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer
  • 18F-AlF-LNC1007 in the evaluation of Breast cancer:comparison with 18F-FDG/18F-FAPI-04 PET/CT
  • Prognostic stratification of metastatic triple-negative breast cancer patients using PET-radiomic features from malignant and tumor-free regions
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Breast Cancer

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire